Ruffo Frank
CIK 0001654450
Chief Financial Officer
Filings
4
Latest Mar 14, 2022
Issuers covered
1
Showing
4 of 4
Page 1
Track record
2 of 2 open-market trades scored (100% price coverage). Returns are signed: a +10% move on a sale shows as -10% (insider was wrong).
| Horizon | Trades | Win rate | Avg | Median | Best | Worst |
|---|---|---|---|---|---|---|
| 30 days | 2 | 50% | -11.7% | -11.7% | +0.6% | -24.1% |
| 90 days | 2 | 100% | +8.0% | +8.0% | +12.7% | +3.3% |
| 180 days | 2 | 50% | -19.7% | -19.7% | +1.9% | -41.3% |
| 365 days | 2 | 50% | +20.9% | +20.9% | +50.7% | -8.8% |
Issuers
Companies where Ruffo Frank has filed
| Ticker | Issuer | Filings | Last filed |
|---|---|---|---|
| ACRS | Aclaris Therapeutics, Inc. | 4 | Mar 14, 2022 |
All filings
4 Form 4 / 4-A filings, newest first
| Filed | Top transaction | Shares | Price | Value | ||
|---|---|---|---|---|---|---|